{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:55:40Z","timestamp":1794272140425,"version":"4.9.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.medj.2025.100888","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:32:38Z","timestamp":1761143558000},"page":"100888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Thirty years of intravenous thrombolysis for acute ischemic stroke: Historical perspectives, evidence from randomized trials, and emerging directions"],"prefix":"10.1016","volume":"7","author":[{"given":"Hugo","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Mouyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Join-Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Mazighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Olivot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3993-1024","authenticated-orcid":false,"given":"Benjamin","family":"Ma\u00efer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100888_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib2","series-title":"The Burden of Stroke in Europe","author":"Stevens","year":"2017"},{"key":"10.1016\/j.medj.2025.100888_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fneur.2017.00651","article-title":"Ischemic Strokes Due to Large-Vessel Occlusions Contribute Disproportionately to Stroke-Related Dependence and Death: A Review","volume":"8","author":"Malhotra","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib120","article-title":"Endovascular therapy for acute ischemic stroke: From a decade of trials to the next frontier","volume":"7","author":"Mouyal","year":"2026","journal-title":"Med"},{"key":"10.1016\/j.medj.2025.100888_bib5","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jama.2016.13647","article-title":"Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis","volume":"316","author":"Saver","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/STROKEAHA.117.020200","article-title":"Late Window Paradox","volume":"49","author":"Albers","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1474-4422(22)00519-1","article-title":"Thrombolysis for acute ischaemic stroke: current status and future perspectives","volume":"22","author":"Tsivgoulis","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/life13112196","article-title":"Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role","volume":"13","author":"Singh","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.medj.2025.100888_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1756286421997368","article-title":"Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence","volume":"14","author":"Tsivgoulis","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.medj.2025.100888_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","article-title":"The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase","volume":"36","author":"Hacke","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","article-title":"PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism","volume":"29","author":"del Zoppo","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/STROKEAHA.123.045193","article-title":"Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial","volume":"55","author":"Li","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/abr.abr_169_18","article-title":"Reteplase: Structure, Function, and Production","volume":"8","author":"Mohammadi","year":"2019","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.medj.2025.100888_bib16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0735-1097(92)90297-Z","article-title":"Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction","volume":"19","author":"Tanswell","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.medj.2025.100888_bib17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2165\/00003088-200241150-00001","article-title":"Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction","volume":"41","author":"Tanswell","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.medj.2025.100888_bib18","first-page":"563","article-title":"Prolonged half-life in the circulation of a chemical conjugate between a pro-urokinase derivative and human serum albumin","volume":"231","author":"Breton","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.medj.2025.100888_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13318-021-00743-8","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Desmoteplase","volume":"47","author":"Piechowski-Jozwiak","year":"2022","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.medj.2025.100888_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1345\/aph.18006","article-title":"Reteplase: a new thrombolytic for the treatment of acute myocardial infarction","volume":"33","author":"Wooster","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.medj.2025.100888_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/15321819.2015.1126600","article-title":"Development and validation of an indirect competitive ELISA for quantification of recombinant staphylokinase in rabbit plasma: Application to pharmacokinetic study","volume":"37","author":"Kumar","year":"2016","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.medj.2025.100888_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/clpt.1987.32","article-title":"Pharmacokinetics of streptokinase in patients based on amidolytic activator complex activity","volume":"41","author":"Grierson","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.medj.2025.100888_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.870331","article-title":"Composition and Organization of Acute Ischemic Stroke Thrombus: A Wealth of Information for Future Thrombolytic Strategies","volume":"13","author":"Desilles","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/STROKEAHA.117.019896","article-title":"Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke","volume":"49","author":"Ducroux","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib25","doi-asserted-by":"crossref","first-page":"e1686","DOI":"10.1212\/WNL.0000000000008395","article-title":"Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis","volume":"93","author":"Di Meglio","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.medj.2025.100888_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24993","article-title":"Neutrophil extracellular traps in ischemic stroke thrombi","volume":"82","author":"Laridan","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.medj.2025.100888_bib28","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/STROKEAHA.116.014181","article-title":"Incidence and Predictors of Early Recanalization After Intravenous Thrombolysis: A Systematic Review and Meta-Analysis","volume":"47","author":"Seners","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.599908","article-title":"Intracranial Hemorrhage After Reperfusion Therapies in Acute Ischemic Stroke Patients","volume":"11","author":"Maier","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib30","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib31","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","author":"National Institute of Neurological","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib33","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib34","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1804355","article-title":"MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset","volume":"379","author":"Thomalla","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib36","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S1474-4422(11)70192-2","article-title":"DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicentre observational study","volume":"10","author":"Thomalla","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib37","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/STROKEAHA.119.028127","article-title":"Thrombolysis With Alteplase at 0.6 mg\/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial","volume":"51","author":"Koga","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib38","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJMoa1813046","article-title":"Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke","volume":"380","author":"Ma","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1474-4422(08)70044-9","article-title":"Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial","volume":"7","author":"Davis","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib40","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/STROKEAHA.120.031800","article-title":"Ischemic Core Overestimation on Computed Tomography Perfusion","volume":"52","author":"Garcia-Tornel","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib41","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/STROKEAHA.119.028337","article-title":"Review of Perfusion Imaging in Acute Ischemic Stroke: From Time to Tissue","volume":"51","author":"Demeestere","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(19)31053-0","article-title":"Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data","volume":"394","author":"Campbell","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib43","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S0140-6736(20)32163-2","article-title":"Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data","volume":"396","author":"Thomalla","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib44","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2025.12063","article-title":"Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: The HOPE Randomized Clinical Trial","volume":"334","author":"Zhou","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jamaneurol.2019.5061","article-title":"Distributional Validity and Prognostic Power of the National Institutes of Health Stroke Scale in US Administrative Claims Data","volume":"77","author":"Saber","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/STROKEAHA.110.593897","article-title":"Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke","volume":"43","author":"Khatri","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.8496","article-title":"Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial","volume":"320","author":"Khatri","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib48","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1001\/jama.2023.7827","article-title":"Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib49","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa1515510","article-title":"Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke","volume":"374","author":"Anderson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/2396987321989865","article-title":"European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur. Stroke J."},{"key":"10.1016\/j.medj.2025.100888_bib51","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.0000000000002129","article-title":"Time window for recanalization in basilar artery occlusion: Speculative synthesis","volume":"85","author":"Lindsberg","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.medj.2025.100888_bib52","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMoa2413344","article-title":"Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours","volume":"392","author":"Yan","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1474-4422(22)00124-7","article-title":"Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial","volume":"21","author":"Kvistad","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib54","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S1474-4422(15)70017-7","article-title":"Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study","volume":"14","author":"Huang","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(22)01054-6","article-title":"Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial","volume":"400","author":"Menon","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(22)02600-9","article-title":"Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial","volume":"401","author":"Wang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib57","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/jama.2024.14721","article-title":"Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial","volume":"332","author":"Meng","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib58","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1474-4422(24)00377-6","article-title":"Tenecteplase versus alteplase for acute stroke within 4.5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial","volume":"23","author":"Muir","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib59","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(22)00171-5","article-title":"Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial","volume":"21","author":"Bivard","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib60","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1474-4422(24)00206-0","article-title":"Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4.5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial","volume":"23","author":"Parsons","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(22)00484-7","article-title":"Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial","volume":"22","author":"Roaldsen","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib62","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa1109842","article-title":"A randomized trial of tenecteplase versus alteplase for acute ischemic stroke","volume":"366","author":"Parsons","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib63","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","article-title":"Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke","volume":"378","author":"Campbell","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib64","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jama.2020.1511","article-title":"Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial","volume":"323","author":"Campbell","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib65","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaneurol.2023.2094","article-title":"Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial","volume":"80","author":"Bala","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib66","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJMoa2310392","article-title":"Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection","volume":"390","author":"Albers","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/svn-2023-002820","article-title":"Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial","volume":"9","author":"Cheng","year":"2024","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib68","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/STROKEAHA.124.048375","article-title":"Tenecteplase Thrombolysis for Stroke up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical Trial","volume":"56","author":"Cheng","year":"2025","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib69","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2402980","article-title":"Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy","volume":"391","author":"Xiong","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJMoa2503867","article-title":"Intravenous Tenecteplase before Thrombectomy in Stroke","volume":"393","author":"Qiu","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib71","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/S0140-6736(24)00921-8","article-title":"Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial","volume":"403","author":"Coutts","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib72","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jama.2021.13827","article-title":"Effect of Thrombectomy With Combined Contact Aspiration and Stent Retriever vs Stent Retriever Alone on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion: The ASTER2 Randomized Clinical Trial","volume":"326","author":"Lapergue","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib73","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ana.26547","article-title":"Tenecteplase Improves Reperfusion across Time in Large Vessel Stroke","volume":"93","author":"Yogendrakumar","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib74","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1161\/STROKEAHA.124.046694","article-title":"Arterial Recanalization During Interhospital Transfer for Thrombectomy","volume":"55","author":"Seners","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib75","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/STROKEAHA.122.036929","article-title":"Role of Intravenous Thrombolytics Prior to Endovascular Thrombectomy","volume":"53","author":"Campbell","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib76","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2001123","article-title":"Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke","volume":"382","author":"Yang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jama.2020.23523","article-title":"Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial","volume":"325","author":"Zi","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib78","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/jama.2020.23522","article-title":"Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial","volume":"325","author":"Suzuki","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib79","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2107727","article-title":"A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke","volume":"385","author":"LeCouffe","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib80","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(22)00537-2","article-title":"Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial","volume":"400","author":"Fischer","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib81","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(22)00564-5","article-title":"Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial","volume":"400","author":"Mitchell","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib82","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(23)01142-X","article-title":"Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials","volume":"402","author":"Majoie","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib83","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2024.0589","article-title":"Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-Analysis","volume":"331","author":"Kaesmacher","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib84","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/STROKEAHA.124.049167","article-title":"Interfacility Transfer for Thrombectomy: A Promising Therapeutic Window","volume":"56","author":"Seners","year":"2025","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib85","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1161\/STROKEAHA.113.001972","article-title":"Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement","volume":"44","author":"Zaidat","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib86","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1161\/STROKEAHA.114.007964","article-title":"Reperfusion within 6 hours outperforms recanalization in predicting penumbra salvage, lesion growth, final infarct, and clinical outcome","volume":"46","author":"Cho","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib87","doi-asserted-by":"crossref","first-page":"e790","DOI":"10.1212\/WNL.0000000000013210","article-title":"Prevalence and Significance of Impaired Microvascular Tissue Reperfusion Despite Macrovascular Angiographic Reperfusion (No-Reflow)","volume":"98","author":"Ng","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.medj.2025.100888_bib88","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jnis-2022-020020","article-title":"Neutrophil activation in patients treated with endovascular therapy is associated with unfavorable outcomes and mitigated by intravenous thrombolysis","volume":"16","author":"Maier","year":"2023","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.medj.2025.100888_bib89","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00281-023-00984-6","article-title":"Neuroimaging is the new \u201cspatial omic\u201d: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke","volume":"45","author":"Maier","year":"2023","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.medj.2025.100888_bib90","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1161\/STROKEAHA.115.010721","article-title":"Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke","volume":"46","author":"Desilles","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib91","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/STROKEAHA.124.045755","article-title":"Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion","volume":"55","author":"Yogendrakumar","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib92","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/STROKEAHA.123.040806","article-title":"Role of Brain Imaging in the Prediction of Intracerebral Hemorrhage Following Endovascular Therapy for Acute Stroke","volume":"54","author":"Seners","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib93","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/23969873221150022","article-title":"European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke","volume":"8","author":"Alamowitch","year":"2023","journal-title":"Eur. Stroke J."},{"key":"10.1016\/j.medj.2025.100888_bib95","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial","volume":"379","author":"Sandercock","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib96","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1747-4949.2011.00747.x","volume":"7","author":"Lorenzano","year":"2012","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib97","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1474-4422(15)00012-5","article-title":"Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial","volume":"14","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib98","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.STR.0000206215.62441.56","article-title":"Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II","volume":"37","author":"Dzialowski","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib99","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/STROKEAHA.109.548602","article-title":"Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR)","volume":"40","author":"Ahmed","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib100","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1161\/STROKEAHA.109.564096","article-title":"Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage","volume":"40","author":"Tsivgoulis","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib101","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(24)00177-7","article-title":"Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group study","volume":"23","author":"Zonneveld","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jamaneurol.2022.4782","article-title":"Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants","volume":"80","author":"Meinel","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25917","article-title":"Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation","volume":"89","author":"Meinel","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib104","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib105","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1161\/STROKEAHA.116.013715","article-title":"Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke)","volume":"47","author":"von Kummer","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100888_bib106","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jama.2022.0948","article-title":"Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase","volume":"327","author":"Kam","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib107","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jamaneurol.2019.2109","article-title":"Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study","volume":"76","author":"Sarraj","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.medj.2025.100888_bib108","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJMoa2214403","article-title":"Trial of Endovascular Thrombectomy for Large Ischemic Strokes","volume":"388","author":"Sarraj","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib109","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJMoa2213379","article-title":"Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct","volume":"388","author":"Huo","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib110","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa2118191","article-title":"Endovascular Therapy for Acute Stroke with a Large Ischemic Region","volume":"386","author":"Yoshimura","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib111","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(23)02032-9","article-title":"Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial","volume":"402","author":"Bendszus","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib112","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jama.2024.13933","article-title":"Thrombectomy for Stroke With Large Infarct on Noncontrast CT: The TESLA Randomized Clinical Trial","volume":"332","author":"Yoo","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib113","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1056\/NEJMoa2314063","article-title":"Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size","volume":"390","author":"Costalat","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib114","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209398","article-title":"Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core","volume":"103","author":"Gerschenfeld","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.medj.2025.100888_bib115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa2103879","article-title":"Prospective, Multicenter, Controlled Trial of Mobile Stroke Units","volume":"385","author":"Grotta","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib116","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","article-title":"Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial","volume":"380","author":"Zinkstok","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100888_bib117","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jama.2023.0550","article-title":"Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100888_bib118","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa2314779","article-title":"Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke","volume":"391","author":"Adeoye","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100888_bib119","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2503678","article-title":"Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke","volume":"393","author":"Tao","year":"2025","journal-title":"N. Engl. J. Med."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025003150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025003150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:16:15Z","timestamp":1767975375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634025003150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666634025003150"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100888","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thirty years of intravenous thrombolysis for acute ischemic stroke: Historical perspectives, evidence from randomized trials, and emerging directions","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100888"}}